ArticleTranslational vision science & technology2026
Serum Klotho Levels and Major Age-Related Ocular Disorders: A Cross-Sectional and Genetic Association Study.
Article in Translational vision science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To examine the association between serum Klotho levels and the prevalence of glaucoma, cataract, and retinal disease, and to explore the potential causal relationship between Klotho and glaucoma. Methods: Data from the 2007-2008 National Health and Nutrition Examination Survey were used, including participants aged 40 years and older. Serum Klotho levels were analyzed both as a continuous variable and by quartiles. Logistic regression analysis was performed to assess the associations between serum Klotho levels and ocular disorders. Bidirectional two-sample Mendelian randomization (MR) was used to assess a causal relationship between serum Klotho and glaucoma. Results: A total of 2952 participants were included in the glaucoma analysis. Higher serum Klotho levels were positively associated with glaucoma risk (odds ratio [OR] = 1.05 per 100 pg/mL increase; 95% confidence interval [CI], 1.01-1.09; P = 0.006). Individuals in the highest Klotho quartile had significantly greater glaucoma risk (OR = 1.47; 95% CI, 1.07-2.03; P = 0.02). MR analyses found no evidence of a causal relationship between Klotho and glaucoma in either direction. No significant associations were observed between serum Klotho and cataract (n = 2950) or retinal disease (n = 2637). Conclusions: Higher circulating Klotho levels are associated with an increased prevalence of glaucoma, suggesting a more complex relationship than the previously presumed protective role of Klotho in glaucoma. The lack of genetic evidence for causality suggests this systemic-level association is unlikely to be causal, highlighting the need to investigate whether circulating Klotho reflects distinct processes from those involving its local expression within ocular tissues. Translational Relevance: These findings highlight the potential of circulating Klotho as a systemic biomarker for glaucoma risk assessment, while emphasizing that its role in ocular pathophysiology requires separate investigation of local expression and function.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.